Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

Contributed by: PR Newswire

Tags

IMPLANTICA-RefluxStop

More Like This

Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal

Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)

Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany - presented at the AUGIS meeting in UK

Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

Implantica submits FDA PMA application Clinical Module 2 for RefluxStop™ for U.S. market approval

Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy

Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback

Implantica announces continuing progress in modular PMA application to FDA for RefluxStop™